Comparison of oncological outcomes between neoadjuvant and adjuvant chemotherapy combined with surgery for resectable synchronous colorectal liver metastases

Journal of Surgical Research

Volumn 182, Issue 2, 2013, Pages 257-263

  Oh, Seung Yeop ^a   Kim, Do Yoon ^a   Kim, Young Bae ^a   Suh, Kwang Wook ^a  

^a Ajou University School of Medicine   (South Korea)

Author keywords

Adjuvant; chemotherapy; FOLFOX; Neoadjuvant

Indexed keywords

FLUOROURACIL; FOLINIC ACID; IRINOTECAN; OXALIPLATIN;

ADJUVANT CHEMOTHERAPY; ADULT; ARTICLE; CANCER CHEMOTHERAPY; CLINICAL ARTICLE; COLORECTAL LIVER METASTASIS; FEMALE; FOLLOW UP; HUMAN; LIVER RESECTION; MALE; MULTIPLE CYCLE TREATMENT; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PRIORITY JOURNAL; RECURRENCE FREE SURVIVAL;

ADULT; AGED; CHEMOTHERAPY, ADJUVANT; COLORECTAL NEOPLASMS; COMBINED MODALITY THERAPY; FEMALE; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; NEOADJUVANT THERAPY; NEOPLASMS, MULTIPLE PRIMARY; TREATMENT OUTCOME;

EID: 84877715526     PISSN: 00224804     EISSN: 10958673     Source Type: Journal    
DOI: 10.1016/j.jss.2012.10.927     Document Type: Article

References (23)

1. N. Kemeny The management of resectable and unresectable liver metastases from colorectal cancer Curr Opin Oncol 22 2010 364
2. A. de Gramont, A. Figer, and M. Seymour Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer J Clin Oncol 18 2000 2938
3. J.Y. Douillard, D. Cunningham, and A.D. Roth Irinotecan combined with fluorouracil compared with fluorouracil alone as first-line treatment for metastatic colorectal cancer: a multicenter randomized trial Lancet 355 2000 1041
4. T.C. Chua, A. Saxena, and W. Liauw Systematic review of randomized and nonrandomized trials of the clinical response and outcomes of neoadjuvant systemic chemotherapy for resectable colorectal liver metastases Ann Surg Oncol 17 2010 492
5. N. Lubezky, R. Geva, and E. Shmueli Is there a survival benefit to neoadjuvant versus adjuvant chemotherapy, combined with surgery for resectable colorectal liver metastases? World J Surg 33 2009 1028
6. R.C. Martin 2nd, V. Augenstein, and N.P. Reuter Simultaneous versus staged resection for synchronous colorectal cancer liver metastases J Am Coll Surg 208 2009 842
7. S.K. Reddy, M.A. Morse, and H.I. Hurwitz Addition of bevacizumab to irinotecan- and oxaliplatin-based preoperative chemotherapy regimens does not increase morbidity after resection of colorectal liver metastases J Am Coll Surg 206 2008 96
8. C.R. Scoggins, M.L. Campbell, and C.S. Landry Preoperative chemotherapy does not increase morbidity or mortality of hepatic resection for colorectal cancer metastases Ann Surg Oncol 16 2009 35
9. E.A. Eisenhauer, P. Therasse, and J. Bogaerts New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1) Eur J Cancer 45 2009 228
10. P.C. Simmonds, J.N. Primrose, and J.L. Colquitt Surgical resection of hepatic metastases from colorectal cancer: a systematic review of published studies Br J Cancer 94 2006 982
11. M. Rees, P.P. Tekkis, and F.K. Welsh Evaluation of long-term survival after hepatic resection for metastatic colorectal cancer: a multifactorial model of 929 patients Ann Surg 247 2008 125
12. Y. Fong, J. Fortner, and R.L. Sun Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases Ann Surg 230 1999 309
13. V.P. Khatri, N.J. Petrelli, and J. Belghiti Extending the frontiers of surgical therapy for hepatic colorectal metastases: is there a limit? J Clin Oncol 23 2005 8490
14. E. Mitry, A.L. Fields, and H. Bleiberg Adjuvant chemotherapy after potentially curative resection of metastases from colorectal cancer: a pooled analysis of two randomized trials J Clin Oncol 26 2008 4906
15. M. Ychou, W. Hohenberger, and S. Thezenas A randomized phase III study comparing adjuvant 5-fluorouracil/folinic acid with FOLFIRI in patients following complete resection of liver metastases from colorectal cancer Ann Oncol 20 2009 1964
16. B. Nordlinger, H. Sorbye, and B. Glimelius Perioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC Intergroup trial 40983): a randomized controlled trial Lancet 371 2008 1007
17. S. Benoist, and B. Nordlinger The role of preoperative chemotherapy in patients with resectable colorectal liver metastases Ann Surg Oncol 16 2009 2385
18. T. Aloia, M. Sebagh, and M. Plasse Liver histology and surgical outcomes after preoperative chemotherapy with fluorouracil plus oxaliplatin in colorectal cancer liver metastases J Clin Oncol 24 2006 4983
19. J.N. Vauthey, T.M. Pawlik, and D. Ribero Chemotherapy regimen predicts steatohepatitis and an increase in 90-day mortality after surgery for hepatic colorectal metastases J Clin Oncol 24 2006 2065
20. M. Karoui, C. Penna, and M. Amin-Hashem Influence of preoperative chemotherapy on the risk of major hepatectomy for colorectal liver metastases Ann Surg 243 2006 1
21. R. Adam, D.A. Wicherts, and R.J. de Haas Complete pathologic response after preoperative chemotherapy for colorectal liver metastases: myth or reality? J Clin Oncol 26 2008 1635
22. P.J. Allen, N. Kemeny, and W. Jarnagin Importance of response to neoadjuvant chemotherapy in patients undergoing resection of synchronous colorectal liver metastases J Gastrointest Surg 7 2003 109
23. C. Tournigand, T. André, and E. Achille FOLFIRI followed by FOLFOX6 or the reverse sequence in advanced colorectal cancer: a randomized GERCOR study J Clin Oncol 22 2004 229